• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Recro Pharma, Inc. (REPH)

    -NasdaqCM
    7.48 Down 0.11(1.45%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.59
    Open:N/A
    Bid:7.13 x 300
    Ask:N/A
    1y Target Est:28.67
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:7.17 - 7.66
    52wk Range:2.36 - 15.40
    Volume:56,174
    Avg Vol (3m):154,575
    Market Cap:58.66M
    P/E (ttm):N/A
    EPS (ttm):-1.73
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for REPH

    Comparison

    Symbol% ChgMkt Cap
    REPHDown 1.45%58.66M
    JNJDown 1.04%281.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.18
    Quarterly EPS Est (Jun-15) :-0.52
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Recro Pharma, Inc., a clinical stage specialty pharmaceutical company, engages in developing non-opioid therapeutics for the treatment of pain. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-ope... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback